Minimal residual disease (MRD) detection of the t(12;21) TEL-AML1 fusion-transcript by quantitative real-time RT-PCR.

被引：0
|
作者：
Pallisgaard, N [1 ]
Hokland, P [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Hematol, DK-8000 Aarhus, Denmark
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1620
引用
收藏
页码：392A / 392A
页数：1
相关论文
共 50 条
  • [31] Quantitative analysis of WT1 gene for detection of minimal residual disease in acute leukemia by real-time RT-PCR
    Ghaffari, S. H.
    Hemmati, T.
    Rostami, S.
    Alimoghaddam, K.
    Ghavamzadeh, A.
    EJC SUPPLEMENTS, 2005, 3 (02): : 285 - 285
  • [32] Novel 5′ exonuclease-based real-time PCR assay for the detection of TEL-AML1 fusion in childhood acute lymphoblastic leukemia (ALL).
    Seeger, K
    Kreuzer, KA
    Schmidt, CA
    Buchwald, D
    Lass, U
    Schmitt, G
    Taube, T
    Köchling, J
    Beyermann, B
    Huhn, D
    Henze, G
    BLOOD, 1998, 92 (10) : 392A - 393A
  • [33] Quantitative analysis of TEL/AML1 fusion transcripts by real-time RT-PCR assay in childhood acute lymphoblastic leukemia
    P Ballerini
    J Landman Parker
    I Laurendeau
    M Olivi
    M Vidaud
    M Adam
    G Leverger
    I Gerota
    YE Cayre
    I Bièche
    Leukemia, 2000, 14 : 1526 - 1528
  • [34] Quantitative analysis of TEL/AML1 fusion transcripts by real-time RT-PCR assay in childhood acute lymphoblastic leukemia
    Ballerini, P
    Parker, JL
    Laurendeau, I
    Olivi, M
    Vidaud, M
    Leverger, G
    Gerota, I
    Cayre, YE
    Bièche, I
    LEUKEMIA, 2000, 14 (08) : 1526 - 1528
  • [35] Minimal residual disease (MRD) analysis in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)] by real time PCR (RT-PCR) and flow cytometry (FC).
    Perea, G
    Lasa, A
    Aventin, A
    Domingo, A
    Villamor, N
    de Llano, MPQ
    Llorente, A
    Junca, J
    Palacios, C
    Fernandez, C
    Gilallart, M
    Font, L
    Tormo, M
    Florensa, L
    Bargay, J
    Marti, JM
    Vivancos, P
    Torres, P
    Berlanga, J
    Brunet, S
    Sierra, J
    Nomdedeu, JF
    BLOOD, 2004, 104 (11) : 817A - 817A
  • [36] Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD)
    K Olsson
    CJ Gerard
    J Zehnder
    C Jones
    R Ramanathan
    C Reading
    EG Hanania
    Leukemia, 1999, 13 : 1833 - 1842
  • [37] Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD)
    Olsson, K
    Gerard, CJ
    Zehnder, J
    Jones, C
    Ramanathan, R
    Reading, C
    Hanania, EG
    LEUKEMIA, 1999, 13 (11) : 1833 - 1842
  • [38] Quantitation of minimal residual disease in t(8;21)-positive acute myelogenous leukemia patients using real-time quantitative RT-PCR
    Sugimoto, T
    Das, H
    Imoto, S
    Murayama, T
    Gomyo, H
    Chakraborty, S
    Taniguchi, R
    Isobe, T
    Nakagawa, T
    Nishimura, R
    Koizumi, T
    AMERICAN JOURNAL OF HEMATOLOGY, 2000, 64 (02) : 101 - 106
  • [39] DIFFICULTIES OF MINIMAL RESIDUAL DISEASE MONITORING BY NESTED PCR IN TEL-AML1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN
    Colita, A.
    Radu, L. E.
    Dumitru, J.
    Dragomir, M.
    Jardan, C.
    Gheorghe, A.
    Coriu, D.
    Arion, C.
    HAEMATOLOGICA, 2014, 99 : 549 - 549
  • [40] THE T(12-21) OF ACUTE LYMPHOBLASTIC-LEUKEMIA RESULTS IN A TEL-AML1 GENE FUSION
    ROMANA, SP
    MAUCHAUFFE, M
    LECONIAT, M
    CHUMAKOV, I
    LEPASLIER, D
    BERGER, R
    BERNARD, OA
    BLOOD, 1995, 85 (12) : 3662 - 3670
12345